Orsimet MV 2mg/500mg/0.20mg Tablet
By Orsimet MV
Rx
10 Tablet in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.20mg)

Manufacturer - Orchis Pharma
orchid towers' #313, valluvar kottam high road nungambakkam chennai - 600 034 tamil nadu, india

Expires on or after
April, 2026

liver
When using Orsimet MV 2mg/500mg/0.20mg Tablet, it is important to proceed with caution if you have liver disease. Patients with liver issues may require a dose adjustment of Orsimet MV 2mg/500mg/0.20mg Tablet, so consulting your doctor is crucial. Typically, the medication is initiated at a low dose for individuals with mild to moderate liver disease. However, it is advised not to use Orsimet MV 2mg/500mg/0.20mg Tablet in cases of severe liver disease. It's essential to prioritize your liver health and seek guidance from a healthcare professional when considering the use of Orsimet MV 2mg/500mg/0.20mg Tablet.

kidney
Orsimet MV 2mg/500mg/0.20mg Tablet may not be safe for use in patients with kidney disease. It is advised to consult your doctor before taking this medication. Avoid using Orsimet MV in case of severe kidney disease.

alcohol
It is not recommended to drink alcohol while taking Orsimet MV 2mg/500mg/0.20mg Tablet.

driving
If you experience low or high blood sugar symptoms, avoid driving while using Orsimet MV 2mg/500mg/0.20mg Tablet.

pregnancy
Orsimet MV 2mg/500mg/0.20mg Tablet may be harmful during pregnancy. Animal studies have shown negative effects on the developing baby. Your doctor will consider the risks and benefits before prescribing. It is advised to consult your doctor regarding its use in pregnancy.

breastfeeding
Caution is advised regarding breastfeeding while using Orsimet MV 2mg/500mg/0.20mg Tablet as it may be unsafe. Limited data indicates a risk of the drug passing into breastmilk and potentially causing harm to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹112.5
₹125
10% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025
